Research output

Research output per year 1960 1973 1980 1982 1990 1993 1996 1997 1998 1999 2002 2003 2004 2005 2008 2011 2012 2013 2014 2022

• 26837 Citations
• 93 Scopus h-Index
• 366 Article
• 29 Review article
• 17 Letter
• 15 Chapter
• 20 More
  • 9 Comment/debate
  • 8 Editorial
  • 2 Conference contribution
  • 1 Foreword/postscript

Research output per year

Research output per year

Search results

• 2018

  The unfolding landscape of the congenital myasthenic syndromes

  Engel, A. G., Shen, X. M. & Selcen, D., 2018, In: Annals of the New York Academy of Sciences. 1413, 1, p. 25-34 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Sequencing Method 95%
  • Neuromuscular 88%
  • Acetylcholine 67%
  • Defects 62%
  6 Scopus citations
• 2017

  Congenital Myasthenic Syndromes in 2018

  Engel, A. G., Aug 1 2017, In: Current neurology and neuroscience reports. 18, 8, 46.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Vesicle-Associated Membrane Protein 1 23%
  • Synaptotagmin II 22%
  • citrate-binding transport protein 22%
  • choline transporter 20%
  31 Scopus citations
• 2015

  Congenital myasthenic syndromes: Pathogenesis, diagnosis, and treatment

  Engel, A. G., Shen, X. M., Selcen, D. & Sine, S. M., Apr 1 2015, In: The Lancet Neurology. 14, 4, p. 420-434 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Motor Endplate 15%
  • Cholinergic Agonists 13%
  • Adrenergic Agonists 13%
  • Exome 12%
  243 Scopus citations
• 2013

  Message from the editors to our reviewers

  Gross, R. A., Knopman, D. S., Cascino, G. D., Corboy, J. R., Elkind, M. S. V., Engel, A. G., Mink, J. W., Ransohoff, R. M., Uitti, R. J. & Worrall, B. B., Jan 1 2013, In: Neurology. 80, 1, p. 5-12 8 p.

  Research output: Contribution to journal › Review article › peer-review
• 2012

  Congenital myasthenic syndromes in 2012

  Engel, A. G., Feb 2012, In: Current neurology and neuroscience reports. 12, 1, p. 92-101 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • peripheral membrane protein 43K 37%
  • Agrin 32%
  • fructose-6-phosphate 31%
  • Motor Endplate 30%
  33 Scopus citations

• Current status of the congenital myasthenic syndromes

  Engel, A. G., Feb 2012, In: Neuromuscular Disorders. 22, 2, p. 99-111 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • peripheral membrane protein 43K 22%
  • Plectin 20%
  • Congenital Structural Myopathies 19%
  • Agrin 19%
  109 Scopus citations

• Muscle restricted vasculitis causing dropped head syndrome: A case report and review of the literature

  Nielsen, A. A., Smith, B. E., Engel, A. G. & Bosch, E. P., Mar 1 2012, In: Journal of clinical neuromuscular disease. 13, 3, p. 117-121 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Paraspinal Muscles 100%
  • Vasculitis 76%
  • Head 54%
  • Muscular Diseases 53%
  • Muscles 44%
  1 Scopus citations
• 2006

  Recent advances in Cys-loop receptor structure and function

  Sine, S. M. & Engel, A. G., Mar 23 2006, In: Nature. 440, 7083, p. 448-455 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Cysteine Loop Ligand-Gated Ion Channel Receptors 100%
  • Neurotransmitter Agents 49%
  • Mutation 31%
  • Membrane Potentials 27%
  • Ions 23%
  405 Scopus citations
• 2005

  Current understanding of congenital myasthenic syndromes

  Engel, A. G. & Sine, S. M., Jun 2005, In: Current Opinion in Pharmacology. 5, 3 SPEC. ISS., p. 308-321 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Mutation 53%
  • Choline O-Acetyltransferase 51%
  • Cholinergic Receptors 46%
  • Choline 45%
  137 Scopus citations

• Sporadic late onset nemaline myopathy

  Chahin, N., Selcen, D. & Engel, A. G., Oct 25 2005, In: Neurology. 65, 8, p. 1158-1164 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nemaline Myopathies 100%
  • Paraproteinemias 77%
  • Electron Microscopy 21%
  • Actinin 16%
  • Frozen Sections 13%
  86 Scopus citations
• 2003

  Congenital myasthenic syndromes: A diverse array of molecular targets

  Engel, A. G., Ohno, K. & Sine, S. M., Jun 2003, In: Journal of Neurocytology. 32, 5-8, p. 1017-1037 21 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Mutation 35%
  • NAV1.4 Voltage-Gated Sodium Channel 31%
  • peripheral membrane protein 43K 27%
  • Choline O-Acetyltransferase 19%
  20 Scopus citations

• E-box mutations in the RAPSN promoter regions in eight cases with congenital myasthenic syndrome

  Ohno, K., Sadeh, M., Blatt, I., Brengman, J. M. & Engel, A. G., Apr 1 2003, In: Human molecular genetics. 12, 7, p. 739-748 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Genetic Promoter Regions 61%
  • peripheral membrane protein 43K 55%
  • Consensus Sequence 36%
  • Mutation 35%
  78 Scopus citations
• 2002

  Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.

  Ohno, K. & Engel, A. G., Jan 2002, In: Current neurology and neuroscience reports. 2, 1, p. 78-88 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Neuromuscular Junction 73%
  • Cholinergic Receptors 55%
  • Acetylcholine 46%
  • Mutation 35%
  33 Scopus citations

• Congenital myasthenic syndromes.

  Engel, A. G. & Ohno, K., 2002, In: Advances in neurology. 88, p. 203-215 13 p.

  Research output: Contribution to journal › Review article › peer-review
  11 Scopus citations
• 1999

  Congenital myasthenic syndromes: Recent advances

  Engel, A. G., Ohno, K. & Sine, S. M., Feb 1999, In: Archives of neurology. 56, 2, p. 163-167 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Cholinergic Receptors 69%
  • Mutation 63%
  • Syndrome 55%
  • Acetylcholine 25%
  99 Scopus citations

• Congenital myasthenic syndromes.

  Engel, A. G., Jan 1999, In: Journal of child neurology. 14, 1, p. 38-41 4 p.

  Research output: Contribution to journal › Review article › peer-review
  5 Scopus citations
• 1998

  Molecular basis of congenital myasthenic syndromes: Mutations in the acetylcholine receptor

  Engel, A. G., Ohno, K., Wang, H. L., Milone, M. & Sine, S. M., May 1 1998, In: Neuroscientist. 4, 3, p. 185-194 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Cholinergic Receptors 69%
  • Mutation 35%
  • Acetylcholine 29%
  • Kinetics 9%
  22 Scopus citations
• 1997

  Cellular immune mechanisms in inflammatory myopathies

  Hohlfeld, R., Engel, A. G., Goebels, N. & Behrens, L., 1997, In: Current opinion in rheumatology. 9, 6, p. 520-526 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Myositis 100%
  • Muscles 49%
  • Inclusion Body Myositis 40%
  • Perforin 35%
  • T-Lymphocytes 33%
  72 Scopus citations
• 1994

  Congenital myasthenic syndromes

  Engel, A. G., 1994, In: Neurologic clinics. 12, 2, p. 401-437 37 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital Myasthenic Syndromes 100%
  • Clinical Laboratory Techniques 70%
  31 Scopus citations
• 1993

  Cellular mechanisms in inflammatory myopathies.

  Hohlfeld, R., Goebels, N. & Engel, A. G., Nov 1993, In: Baillière's clinical neurology. 2, 3, p. 617-635 19 p.

  Research output: Contribution to journal › Review article › peer-review

  • Myositis 100%
  • Skeletal Muscle Fibers 57%
  • Muscles 49%
  • Inclusion Body Myositis 45%
  • T-Lymphocytes 38%
  33 Scopus citations
• 1992

  The role of gamma-delta T lymphocytes in inflammatory muscle disease

  Hohlfeld, R. & Engel, A. G., Jan 1 1992, In: Chemical Immunology. 53, p. 75-85 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Intraepithelial Lymphocytes 100%
  • Myositis 94%
  • Muscles 46%
  • Inclusion Body Myositis 22%
  • T-Lymphocytes 19%
  10 Scopus citations
• 1990

  Congenital disorders of neuromuscular transmission

  Engel, A. G., 1990, In: Seminars in Neurology. 10, 1, p. 12-26 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities 100%
  • Neuromuscular Junction 31%
  • Safety 31%
  • Microelectrodes 29%
  • Neurologists 29%
  8 Scopus citations

• Immune effector mechanisms in inflammatory myopathies.

  Engel, A. G., Arahata, K. & Emslie-Smith, A., 1990, In: Research publications - Association for Research in Nervous and Mental Disease. 68, p. 141-157 17 p.

  Research output: Contribution to journal › Review article › peer-review

  • Myositis 100%
  • Muscles 49%
  • T-Lymphocytes 33%
  • Sarcolemma 17%
  • Antibodies 15%
  66 Scopus citations
• 1989

  Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle

  De Visser, M., Emslie-Smith, A. M. & Engel, A. G., Dec 1989, In: Journal of the neurological sciences. 94, 1-3, p. 181-192 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Dermatomyositis 100%
  • Capillaries 78%
  • Muscles 48%
  • Endothelial Cells 24%
  • Complement Membrane Attack Complex 22%
  94 Scopus citations
• 1987

  Congenital myasthenic syndromes.

  Engel, A. G. & Lambert, E. H., 1987, In: Electroencephalography and clinical neurophysiology. Supplement. 39, p. 91-102 12 p.

  Research output: Contribution to journal › Review article › peer-review
  28 Scopus citations
• 1983

  Carnitine metabolism and deficiency syndromes

  Rebouche, C. J. & Engel, A. G., 1983, In: Mayo Clinic proceedings. 58, 8, p. 533-540 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Carnitine 100%
  • Myopathic carnitine deficiency 15%
  • acylcarnitine 9%
  • Mitochondrial Membranes 7%
  • Esters 7%
  133 Scopus citations
• 1972

  Neuromuscular manifestations of Graves' disease.

  Engel, A. G., Dec 1 1972, In: Mayo Clinic proceedings. 47, 12, p. 919-925 7 p.

  Research output: Contribution to journal › Review article › peer-review
  43 Scopus citations
• 1966

  Treatment of metabolic and endocrine myopathies.

  Engel, A. G., Mar 1 1966, In: Modern treatment. 3, 2, p. 313-325 13 p.

  Research output: Contribution to journal › Review article › peer-review
  2 Scopus citations
• 1961

  Studies in familial periodic paralysis

  Shy, G. M., Wanko, T., Rowley, P. T. & Engel, A. G., Jan 1961, In: Experimental Neurology. 3, 1, p. 53-121 69 p.

  Research output: Contribution to journal › Review article › peer-review

  • Familial Periodic Paralysis 100%
  • Paralysis 52%
  • Aldosterone 23%
  • Muscles 13%
  • Hormones 10%
  53 Scopus citations